Medicines Co. (MDCO) Reports Q3 Loss of $0.70

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. CVS
9. SPY
10. XYZ

Go back to Medicines Co. (MDCO) Reports Q3 Loss of $0.70

The Medicines Company Reports Third-Quarter 2018 Results

November 8, 2018 7:00 AM EST

PARSIPPANY, N.J.--(BUSINESS WIRE)-- The Medicines Company (NASDAQ: MDCO) today reported its financial results for the third quarter ended September 30, 2018.

During the third quarter of 2018, we continued to advance inclisiran through Phase III trials and other, key development steps, said Clive Meanwell, M.D., Ph.D., Chief Executive Officer of The Medicines Company. We continue to be impressed by the blinded safety data emerging from the Phase III trials, and expect our clinical momentum to continue into 2019, moving toward anticipated clinical data readout early in the second half of... More